OriCiro Genomics K.K. is a company that specializes in cell-free DNA synthesis and amplification technologies, according to a Jan. 4 Moderna news release.
“With this acquisition, we obtain best-in-class tools for cell-free synthesis and amplification of plasmid DNA, a key building block in mRNA manufacturing,” Stéphane Bancel, CEO of Moderna, said in the release. “OriCiro’s technology strategically complements our manufacturing expertise and further accelerates our research and development engine.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
